Skip to main content
H

HANS BIOMED CORPORATION — Investor Relations & Filings

Ticker · 042520 ISIN · KR7042520007 KO Manufacturing
Open in API
Filings indexed 230 across all filing types
Latest filing 2023-11-28 AGM Information
Country KR South Korea
Listing KO 042520

About HANS BIOMED CORPORATION

http://www.hansbiomed.com/en/

HANS BIOMED CORPORATION is a biotechnology company that develops, manufactures, and sells high-tech medical materials, devices, and biologics. The company's core focus is on regenerative medicine and tissue engineering. Its product portfolio includes silicone breast implants, allograft tissue products for skin and bone grafts, and absorbable lifting sutures for aesthetic procedures. The company also offers professional cosmeceutical products. HANS BIOMED supports its operations through a dedicated tissue engineering research laboratory and a human tissue bank, aiming to provide innovative solutions for the global medical and aesthetic markets.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for HansBiomed. It outlines the date, location, and specific agenda items (approval of financial statements, election of directors, and remuneration limits). This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2023-11-28 Korean
신주인수권행사(제2회차)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing from HansBiomed regarding the exercise of stock warrants (신주인수권행사). It details the number of shares issued, the exercise price, and the impact on total outstanding shares. This falls under the category of capital changes resulting from the exercise of financial instruments, which is classified as Share Issue/Capital Change (SHA).
2023-10-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure for insiders (directors, executives, and major shareholders) to report changes in their shareholdings, which falls under the category of 'Director's Dealing' (DIRS).
2023-10-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure for corporate insiders (directors/major shareholders) regarding their transactions and holdings of company securities. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider trades and changes in ownership by company executives.
2023-10-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership by major shareholders (Hwang Ho-chan and others) due to the exercise of stock warrants (BW). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-10-05 Korean
신주인수권행사(제2회차)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing from HansBiomed regarding the exercise of stock warrants (신주인수권행사). It details the number of shares exercised, the impact on total issued shares, and the schedule for listing the new shares. This falls under the category of capital changes resulting from the exercise of financial instruments, which is classified as Share Issue/Capital Change.
2023-10-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.